Pulmonary embolism (PE) is a life-threatening condition in which a blood clot travels to the lungs, lodging in the pulmonary arteries and blocking blood flow. It is a serious medical emergency that requires prompt diagnosis and treatment. The risk factors for PE include age, gender, certain medical conditions, lifestyle choices, and family history. In this comprehensive guide, we will explore the risk factors associated with PE and discuss ways to reduce your risk.
Age is one of the most significant risk factors for developing PE. The risk of PE increases with age, with the highest risk group being those over the age of 75. This is likely due to the increased likelihood of developing other medical conditions, such as deep vein thrombosis, which can lead to the formation of a blood clot that can then travel to the lungs.
Women are at a higher risk of developing PE than men. This is likely due to the fact that women tend to have higher levels of hormones, such as estrogen, which can increase the risk of blood clotting. Additionally, women are more likely to take certain medications, such as birth control pills, which can also increase the risk of developing PE.
Certain medical conditions can increase the risk of developing PE. These include cancer, heart disease, stroke, obesity, and inflammatory bowel disease. Additionally, certain medications, such as those used to treat cancer or autoimmune diseases, can also increase the risk of PE.
Certain lifestyle choices can also increase the risk of developing PE. These include smoking, being sedentary, and being immobile for extended periods of time (such as during a long plane flight). Additionally, those who are pregnant or have recently given birth are at an increased risk of developing PE.
Having a family history of PE can also increase the risk of developing the condition. This is likely due to the fact that certain genetic factors can increase the risk of clotting. Additionally, those with a family history of certain medical conditions, such as cancer or heart disease, may also be at an increased risk of developing PE.
Although some risk factors for PE cannot be changed (such as age and family history), there are steps you can take to reduce your risk. These include: • Maintaining a healthy weight. • Exercising regularly. • Not smoking. • Taking medications as prescribed. • Avoiding long periods of immobility, such as during a long plane flight. • Wearing compression stockings if you are at an increased risk of blood clots.
Pulmonary embolism is a serious medical emergency that requires prompt diagnosis and treatment. The risk factors for PE include age, gender, certain medical conditions, lifestyle choices, and family history. By understanding the risk factors associated with PE and taking steps to reduce your risk, you can help to prevent this potentially life-threatening condition.
1.
Data indicate 1 in 3 US adults unaware of connection between HPV and cancers
2.
Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.
3.
New imaging probe helps track prostate cancer and possibly treat it before resistance develops
4.
A novel blood test may enable the early identification of common, fatal cancers.
5.
Children living near oil and gas wells face higher risk of rare leukemia, studies show
1.
What You Need to Know About the Early Warning Signs of Colon Cancer
2.
Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer
3.
Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells
4.
Unlocking the Potential of Reticulocytes: The Key to Enhanced Blood Production
5.
Unlocking the Potential of Polatuzumab for Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Navigating the Complexities of Ph Negative ALL - Part XII
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation